252 related articles for article (PubMed ID: 24242074)
1. Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.
Liu J; Wang LN
CNS Drugs; 2014 Jan; 28(1):63-8. PubMed ID: 24242074
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme Q10 a mitochondrial restorer for various brain disorders.
Pradhan N; Singh C; Singh A
Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2197-2222. PubMed ID: 34596729
[TBL] [Abstract][Full Text] [Related]
3. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues.
Orsucci D; Mancuso M; Ienco EC; LoGerfo A; Siciliano G
Curr Med Chem; 2011; 18(26):4053-64. PubMed ID: 21824087
[TBL] [Abstract][Full Text] [Related]
4. Coenzyme Q10 in neuromuscular and neurodegenerative disorders.
Mancuso M; Orsucci D; Volpi L; Calsolaro V; Siciliano G
Curr Drug Targets; 2010 Jan; 11(1):111-21. PubMed ID: 20017723
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of riluzole for neurodegenerative movement disorders: a systematic review with meta-analysis.
Liu J; Wang LN
Drug Deliv; 2018 Nov; 25(1):43-48. PubMed ID: 29226728
[TBL] [Abstract][Full Text] [Related]
6. Coenzyme Q10 in neurodegenerative diseases.
Shults CW
Curr Med Chem; 2003 Oct; 10(19):1917-21. PubMed ID: 12871093
[TBL] [Abstract][Full Text] [Related]
7. Review of clinical trials for mitochondrial disorders: 1997-2012.
Kerr DS
Neurotherapeutics; 2013 Apr; 10(2):307-19. PubMed ID: 23361264
[TBL] [Abstract][Full Text] [Related]
8. Bioenergetic approaches for neuroprotection in Parkinson's disease.
Beal MF
Ann Neurol; 2003; 53 Suppl 3():S39-47; discussion S47-8. PubMed ID: 12666097
[TBL] [Abstract][Full Text] [Related]
9. Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.
Adhihetty PJ; Beal MF
Neuromolecular Med; 2008; 10(4):275-90. PubMed ID: 19005780
[TBL] [Abstract][Full Text] [Related]
10. Idebenone in Friedreich's ataxia.
Tonon C; Lodi R
Expert Opin Pharmacother; 2008 Sep; 9(13):2327-37. PubMed ID: 18710357
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 and Neurological Diseases.
Mancuso M; Orsucci D; Calsolaro V; Choub A; Siciliano G
Pharmaceuticals (Basel); 2009 Dec; 2(3):134-149. PubMed ID: 27713230
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q10 as a possible treatment for neurodegenerative diseases.
Beal MF
Free Radic Res; 2002 Apr; 36(4):455-60. PubMed ID: 12069110
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme Q10 as a therapy for mitochondrial disease.
Hargreaves IP
Int J Biochem Cell Biol; 2014 Apr; 49():105-11. PubMed ID: 24495877
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of creatine.
Beal MF
Amino Acids; 2011 May; 40(5):1305-13. PubMed ID: 21448659
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q.
Naia L; Ribeiro MJ; Rego AC
Rev Neurosci; 2011 Dec; 23(1):13-28. PubMed ID: 22150069
[TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q10 for Parkinson's disease.
Liu J; Wang L; Zhan SY; Xia Y
Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.
Zhu ZG; Sun MX; Zhang WL; Wang WW; Jin YM; Xie CL
Neurol Sci; 2017 Feb; 38(2):215-224. PubMed ID: 27830343
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial diseases of the brain.
Chaturvedi RK; Flint Beal M
Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
[TBL] [Abstract][Full Text] [Related]
19. Creatine for neuroprotection in neurodegenerative disease: end of story?
Bender A; Klopstock T
Amino Acids; 2016 Aug; 48(8):1929-40. PubMed ID: 26748651
[TBL] [Abstract][Full Text] [Related]
20. Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
Cooper JM; Schapira AH
Biofactors; 2003; 18(1-4):163-71. PubMed ID: 14695932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
